NO20051941L - Kombinasjonskjemoterapisammensetninger og fremgangsmater. - Google Patents
Kombinasjonskjemoterapisammensetninger og fremgangsmater.Info
- Publication number
- NO20051941L NO20051941L NO20051941A NO20051941A NO20051941L NO 20051941 L NO20051941 L NO 20051941L NO 20051941 A NO20051941 A NO 20051941A NO 20051941 A NO20051941 A NO 20051941A NO 20051941 L NO20051941 L NO 20051941L
- Authority
- NO
- Norway
- Prior art keywords
- methods
- combination chemotherapy
- compositions
- chemotherapy compositions
- combination therapies
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000009096 combination chemotherapy Methods 0.000 title 1
- 238000002648 combination therapy Methods 0.000 abstract 2
- 230000001093 anti-cancer Effects 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 abstract 1
- 150000002515 isoflavone derivatives Chemical class 0.000 abstract 1
- 235000008696 isoflavones Nutrition 0.000 abstract 1
- 229930013032 isoflavonoid Natural products 0.000 abstract 1
- 235000012891 isoflavonoids Nutrition 0.000 abstract 1
- 229910052697 platinum Inorganic materials 0.000 abstract 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 abstract 1
- -1 platinum isoflavonoid Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2002951833A AU2002951833A0 (en) | 2002-10-02 | 2002-10-02 | Compositions and therapeutic methods invloving platinum complexes |
| PCT/AU2003/001296 WO2004030662A1 (en) | 2002-10-02 | 2003-10-02 | Combination chemotherapy compositions and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20051941L true NO20051941L (no) | 2005-04-20 |
Family
ID=28679466
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20051941A NO20051941L (no) | 2002-10-02 | 2005-04-20 | Kombinasjonskjemoterapisammensetninger og fremgangsmater. |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US7906554B2 (de) |
| EP (1) | EP1545481A4 (de) |
| JP (1) | JP2006504705A (de) |
| CN (1) | CN100591331C (de) |
| AU (1) | AU2002951833A0 (de) |
| CA (1) | CA2498555A1 (de) |
| HK (1) | HK1083455A1 (de) |
| MX (1) | MXPA05003528A (de) |
| NO (1) | NO20051941L (de) |
| NZ (1) | NZ538583A (de) |
| WO (1) | WO2004030662A1 (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0011903D0 (en) * | 2000-05-18 | 2000-07-05 | Astrazeneca Ab | Combination chemotherapy |
| US20080131968A1 (en) * | 2002-08-28 | 2008-06-05 | Nomir Medical Technologies, Inc. | Near-infrared electromagnetic modification of cellular steady-state membrane potentials |
| EP1686981A4 (de) * | 2003-11-19 | 2011-02-23 | Novogen Res Pty Ltd | Zusammensetzungen und verfahren für die kombinierte strahlentherapie und chemotherapie |
| ATE532777T1 (de) | 2004-09-21 | 2011-11-15 | Marshall Edwards Inc | Substituierte chromanderivate, medikamente und anwendungen in der therapie |
| US8080675B2 (en) | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
| EP2084141A4 (de) * | 2006-10-30 | 2010-07-21 | Novogen Res Pty Ltd | Prävention und reversion von durch chemotherapie induzierter peripherer neuropathie |
| US8178564B2 (en) * | 2006-11-06 | 2012-05-15 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8168662B1 (en) | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8173686B2 (en) | 2006-11-06 | 2012-05-08 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8168661B2 (en) * | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US20110033528A1 (en) * | 2009-08-05 | 2011-02-10 | Poniard Pharmaceuticals, Inc. | Stabilized picoplatin oral dosage form |
| US20100260832A1 (en) * | 2007-06-27 | 2010-10-14 | Poniard Pharmaceuticals, Inc. | Combination therapy for ovarian cancer |
| TW200916094A (en) * | 2007-06-27 | 2009-04-16 | Poniard Pharmaceuticals Inc | Stabilized picoplatin dosage form |
| CN101809024A (zh) * | 2007-07-16 | 2010-08-18 | 铂雅制药公司 | 吡铂的口服制剂 |
| US8292723B2 (en) * | 2007-11-09 | 2012-10-23 | Igt | Gaming system and method for providing team play |
| JP2011511071A (ja) * | 2008-02-08 | 2011-04-07 | ポニアード ファーマシューティカルズ， インコーポレイテッド | 肺癌を治療するためのピコプラチンおよびアムルビシン |
| US20120003270A1 (en) * | 2008-07-30 | 2012-01-05 | Alan James Husband | 6-substituted isoflavonoid compounds and uses thereof |
| WO2011026219A1 (en) * | 2009-09-01 | 2011-03-10 | Lu qing-bin | Combination therapy for cancer comprising a platinum -based antineoplastic agent and a biocompatible electron donor |
| CA2816322A1 (en) | 2010-11-01 | 2012-05-10 | Marshall Edwards, Inc. | Isoflavonoid compositions and methods for the treatment of cancer |
| CN103494838B (zh) * | 2013-09-30 | 2016-05-11 | 武汉大学 | 一种化疗药物组合物 |
| AU2016215515B2 (en) | 2015-02-02 | 2020-04-30 | Mei Pharma, Inc. | Combination therapies |
| AU2017247006B2 (en) * | 2016-04-06 | 2022-05-12 | Noxopharm Limited | Radiotherapy improvements |
| RU2018137897A (ru) * | 2016-04-06 | 2020-05-13 | Ноксофарм Лимитед | Пути улучшения лечения рака |
| AU2017247008B2 (en) | 2016-04-06 | 2022-04-07 | Noxopharm Limited | Isoflavonoid composition with improved pharmacokinetics |
| WO2017181242A1 (en) | 2016-04-22 | 2017-10-26 | Noxopharm Limited | Chemotherapy improvements |
| CN110312439A (zh) | 2016-10-03 | 2019-10-08 | 夏滉 | 用于增强癌症放射治疗的组合物和方法 |
| TWI823853B (zh) | 2017-06-13 | 2023-12-01 | 夏滉 | 敏化劑用於製備藥物的用途 |
| WO2018231937A2 (en) | 2017-06-13 | 2018-12-20 | Houn Simon Hsia | Compositions and methods for enhancing cancer radiotherapy |
| CN111556754A (zh) | 2017-06-13 | 2020-08-18 | 夏滉 | 增强癌症化学疗法的组合物和方法 |
| JP2023519990A (ja) | 2020-03-30 | 2023-05-15 | ノクソファーム リミティド | 感染に関連する炎症の治療のための方法 |
| CN117599041B (zh) * | 2024-01-22 | 2024-05-03 | 中国人民解放军军事科学院军事医学研究院 | 去氢雌马酚及其衍生物作为新型辐射防护剂和细胞保护剂的医药用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4264509A (en) * | 1977-06-08 | 1981-04-28 | Z-L Limited Partnership | Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same |
| GB8626344D0 (en) * | 1986-11-04 | 1986-12-03 | Zyma Sa | Bicyclic compounds |
| JP2514500B2 (ja) | 1991-09-14 | 1996-07-10 | 呉羽化学工業株式会社 | 多剤耐性抑制剤及び発現阻害剤 |
| AUPO203996A0 (en) * | 1996-08-30 | 1996-09-26 | Novogen Research Pty Ltd | Therapeutic uses |
| GB9621757D0 (en) | 1996-10-18 | 1996-12-11 | Ciba Geigy Ag | Phenyl-substituted bicyclic heterocyclyl derivatives and their use |
| AU3456499A (en) * | 1998-03-30 | 1999-10-18 | University Of Mississippi, The | Isoflavones for treating giardiasis and malaria |
| FR2781154B1 (fr) | 1998-07-15 | 2001-09-07 | Lafon Labor | Composition therapeutique a base d'isoflavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques |
| AUPP868599A0 (en) | 1999-02-15 | 1999-03-11 | Novogen Research Pty Ltd | Production of isoflavone derivatives |
| AUPQ008299A0 (en) * | 1999-04-30 | 1999-05-27 | G.J. Consultants Pty Ltd | Isoflavone metabolites |
| AUPQ266199A0 (en) | 1999-09-06 | 1999-09-30 | Novogen Research Pty Ltd | Compositions and therapeutic methods involving isoflavones and analogues thereof |
| US6380405B1 (en) * | 1999-09-13 | 2002-04-30 | Nobex Corporation | Taxane prodrugs |
| FI20001593A (fi) * | 2000-07-03 | 2002-01-04 | Orion Yhtymo Oyj | Comt-entsyymiõ inhiboivaa aktiivisuutta omaavia kumariinijohdannaisia |
| CA2478392A1 (en) | 2002-04-09 | 2003-10-23 | Novogen Research Pty Ltd | Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures |
-
2002
- 2002-10-02 AU AU2002951833A patent/AU2002951833A0/en not_active Abandoned
-
2003
- 2003-10-02 CA CA002498555A patent/CA2498555A1/en not_active Abandoned
- 2003-10-02 CN CN200380100787A patent/CN100591331C/zh not_active Expired - Fee Related
- 2003-10-02 NZ NZ538583A patent/NZ538583A/en not_active Application Discontinuation
- 2003-10-02 MX MXPA05003528A patent/MXPA05003528A/es active IP Right Grant
- 2003-10-02 US US10/530,176 patent/US7906554B2/en not_active Expired - Fee Related
- 2003-10-02 JP JP2004540375A patent/JP2006504705A/ja active Pending
- 2003-10-02 EP EP03798829A patent/EP1545481A4/de not_active Withdrawn
- 2003-10-02 WO PCT/AU2003/001296 patent/WO2004030662A1/en active Application Filing
-
2005
- 2005-04-20 NO NO20051941A patent/NO20051941L/no not_active Application Discontinuation
-
2006
- 2006-03-20 HK HK06103505.6A patent/HK1083455A1/xx not_active IP Right Cessation
-
2007
- 2007-04-05 US US11/730,985 patent/US20080069900A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1545481A4 (de) | 2009-11-11 |
| US20060183728A1 (en) | 2006-08-17 |
| EP1545481A1 (de) | 2005-06-29 |
| AU2002951833A0 (en) | 2002-10-24 |
| US20080069900A1 (en) | 2008-03-20 |
| CA2498555A1 (en) | 2004-04-15 |
| US7906554B2 (en) | 2011-03-15 |
| MXPA05003528A (es) | 2005-06-03 |
| NZ538583A (en) | 2008-03-28 |
| WO2004030662A1 (en) | 2004-04-15 |
| JP2006504705A (ja) | 2006-02-09 |
| CN100591331C (zh) | 2010-02-24 |
| HK1083455A1 (en) | 2006-07-07 |
| CN1694690A (zh) | 2005-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20051941L (no) | Kombinasjonskjemoterapisammensetninger og fremgangsmater. | |
| SE0301700D0 (sv) | Novel compounds | |
| NO20063171L (no) | Endoparasitisidale sammensetninger for topisk anvendelse | |
| CY1116372T1 (el) | Φαρμακευτικα σκευασματα που περιεχουν μεθυλναλτρεξονη | |
| NO20064347L (no) | Substituerte 1,2,3,4-tetrahydroisokinolinderivater | |
| NO20064584L (no) | Tetrahydropyridoindolderivater | |
| CY1110926T1 (el) | Υποκατεστημενες πυραζολο πυριδινες, συνθεσεις που τις περιεχουν, διαδικασια παρασκευης και χρηση | |
| NO20062876L (no) | Sammensetninger til kombinert radio- og kjemoterapi, og fremgangsmater | |
| MX2007003216A (es) | Derivados y medicamentos sustituidos del cromano y su uso en terapias. | |
| DK1951729T3 (da) | Oxygenbundne pyrimidinderivater | |
| SE0301653D0 (sv) | Novel compounds | |
| NO20085373L (no) | P38 inhibitorer, deres fremstilling og anvendelse | |
| NO20005535D0 (no) | Pyrazol-derivater som P-38 MAP kinase-inhibitorer | |
| NO20091509L (no) | Substituerte tetrahydropyrrolopyrazinforbindelser med affinitet KCNQ2/3 K+ kanal og anvendelse derav i medikamenter | |
| NO20062739L (no) | Kontrollert frigivining av topirimat i flytende doseringsform | |
| CY1113282T1 (el) | Αντιικα νουκλεοζιτικα αναλογα | |
| MXPA05011522A (es) | Derivados de 2-acilamino-4-feniltiazol, metodo para su preparacion y su aplicacion en terapeutica. | |
| UA86591C2 (ru) | Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе | |
| NO20062020L (no) | 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika | |
| DE60212949D1 (de) | Antivirale pyrazolopyridin verbindungen | |
| SE0302139D0 (sv) | Novel compounds | |
| SG149077A1 (en) | Pyrimidin-2-amine derivatives and their use as a2b adenosine receptor antagonists | |
| EP1812112A4 (de) | Chemische verbindungen | |
| SE0303541D0 (sv) | New compounds | |
| NO20065898L (no) | 1-heterocyklyl-1,5-dihydro-pyrido[3,2-b]indol-2-oner |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |